Cytek Biosciences, Inc. CTKB Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s other income, net (note 6)?
- Cytek Biosciences, Inc. (CTKB) reported other income, net (note 6) of $565K in Q1 2026.
- How has Cytek Biosciences, Inc.'s other income, net (note 6) changed year-over-year?
- Cytek Biosciences, Inc.'s other income, net (note 6) decreased by 83.8% year-over-year, from $3.49M to $565K.
- What is the long-term trend for Cytek Biosciences, Inc.'s other income, net (note 6)?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s other income, net (note 6) has grown at a 54.9% compound annual growth rate (CAGR), from -$1.53M to $8.8M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.